Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rivastigmine for Intensive Care Unit (ICU) Delirium

This study has been terminated.
(The study is prematurely terminated due to a safety issue)
Sponsor:
Collaborators:
ZonMw: The Netherlands Organisation for Health Research and Development
Novartis
Hersenstichting
Information provided by:
UMC Utrecht
ClinicalTrials.gov Identifier:
NCT00704301
First received: June 20, 2008
Last updated: August 12, 2010
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):